Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2004
07/22/2004US20040142932 treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase activity
07/22/2004US20040142930 excellent phosphodiesterase V (PDE V) inhibitory activity, and being useful as a remedy for the prophylaxis or treatment of penile erectile dysfunction with few side effects
07/22/2004US20040142925 Piperazine derivatives their preparation and uses in therapy
07/22/2004US20040142924 6-Phenylpyridyl-2-amine derivatives useful as NOS inhibitors
07/22/2004US20040142923 inhibitors of urotensin II
07/22/2004US20040142921 treatment and/or prevention of type 2 diabetes and associated metabolic syndrome
07/22/2004US20040142920 acute or chronic transplant rejection or inflammatory or autoimmune diseases
07/22/2004US20040142919 Benzazepinone alpha vintegrin receptor antagonists
07/22/2004US20040142206 substituted with aromatic groups, e.g., 2,2'-dihexyloxy-6,6'dianthracenyl- (or 6,6'-dipyrenyl-) 1,1'-binaphthylene; good solubility in common organic solvents, resist crystallization and can be sublimed in a device fabrication process.
07/22/2004US20040142032 treating of ulcers and other conditions related to gastric hypersecretion such as Zollinger-Ellison Syndrome; free of (+) isomer; inhibits H+,K+-ATPase with out the adverse effects seen upon administration of racemic pantoprazole.
07/22/2004DE10300973A1 Neue Carbonsäuren und deren Ester, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung New carboxylic acids and esters thereof, pharmaceutical compositions containing them and processes for their preparation
07/22/2004DE10300398A1 Verwendung von substituierten 2-Phenylbenzimidazolen als Arzneimittel Use of substituted 2-Phenylbenzimidazolen as drugs
07/22/2004CA2513627A1 Anti-inflammatory medicaments
07/22/2004CA2512183A1 Pyrimidine-4,6-dicarboxylic acid diamides for use as selective mmp 13 inhibitors
07/22/2004CA2511873A1 Modulation of protein functionalities
07/22/2004CA2511859A1 Novel cb 1 receptor inverse agonists
07/22/2004CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators
07/22/2004CA2510050A1 The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives
07/22/2004CA2509758A1 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
07/21/2004EP1439175A1 Pyrimidine compound and medicinal composition thereof
07/21/2004EP1439174A1 4-imidazolin-2-one compounds
07/21/2004EP1439169A1 DIFLUOROALKENE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE SAME, AND INTERMEDIATE THEREFOR
07/21/2004EP1438973A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
07/21/2004EP1438307A2 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
07/21/2004EP1438305A1 Arthropodicidal anthranilamides
07/21/2004EP1438304A1 Novel substituted 4-phenyl-4- 1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists
07/21/2004EP1438302A1 New sulfonamide derivatives as d3-receptor agonists
07/21/2004EP1438298A1 Piperazine derivatives with ccr1 receptor antagonist activity
07/21/2004EP1438296A2 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
07/21/2004EP1438295A2 Azole derivatives and pharmaceutical compositions containing them
07/21/2004EP1438293A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
07/21/2004EP1438292A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
07/21/2004EP1438291A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
07/21/2004EP1438053A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same
07/21/2004EP1438049A2 Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
07/21/2004EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
07/21/2004EP1131316B1 Improved chemical process and pharmaceutical formulation
07/21/2004EP1100786B1 Antiviral pyrimidinedione derivatives and process for the preparation thereof
07/21/2004EP1047692B1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof and methods of treating bacterial and microbial infections with these inhibitors
07/21/2004EP0975604B1 Pyridazinones as inhibitors of cyclooxygenase-2
07/21/2004EP0958282B1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
07/21/2004EP0937040B1 N-substituted 2-cyanopyrrolidines
07/21/2004EP0932402B1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
07/21/2004EP0778857B1 Thermosetting resin compositions containing maleimide and/or vinyl compounds
07/21/2004EP0757685B1 Novel acyclic and cyclic amides as neurotransmitter release enhancers
07/21/2004CN1514833A Novel tyrosine kinase inhibitors
07/21/2004CN1514828A Pyrazole derivatives for treating HIV
07/21/2004CN1514714A Indole/indoline based hybird dyes and indole/indoline based hybrid dye intermediate products
07/21/2004CN1158282C Camptothecine like compound, its preparing method and medicinal composition containing them
07/21/2004CN1158277C Farnesyl transferase inhibitors having piperidine structure and process for preparation thereof
07/21/2004CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity
07/21/2004CN1158267C Thiocyano-triazolyl derivatives and their use as microbicides
07/21/2004CN1158266C Compounds
07/21/2004CN1158263C Method of treating textile
07/21/2004CN1158258C Alpha 1 beta-adrenergic receptor antagonists
07/20/2004US6765102 Heat sensitive materials; ph insensitive; do not lose ionic charge in coated form
07/20/2004US6765095 2,3-disubstituted pyridine derivative, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
07/20/2004US6765019 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
07/20/2004US6765013 Thiazolidinedione derivatives for the treatment of diabetes and other diseases
07/20/2004US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
07/20/2004US6765009 1,4-Disubstituted benzo-fused compounds
07/20/2004US6765008 Pyrrolopyrimidines as CRF antagonists
07/15/2004WO2004058781A1 Phosphonooxy quinazoline derivatives and their pharmaceutical use
07/15/2004WO2004058776A1 Therapeutic agents
07/15/2004WO2004058762A1 Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
07/15/2004WO2004058761A1 Pyrazole compounds as integrin receptor antagonists derivatives
07/15/2004WO2004058754A1 Benzoazolypiperazine derivatives having mglur1- and mglur5-antagonistic activity
07/15/2004WO2004058745A1 Optically active dihydropyridine derivative
07/15/2004WO2004058744A1 Derivative of 5-(4-bromophenyl)-1-(2,4-dichlorophenly)-4-ethyl-n-(piperidine-1-yl)-1h-pyrazol-3-carboxamide, the preparation and therapeutic use thereof
07/15/2004WO2004058743A1 Novel substituted nitrogen-containing heterobicycles and use thereof as factor xa inhibitors
07/15/2004WO2004058742A1 Benzocycloheptapyridine compounds
07/15/2004WO2004058741A1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
07/15/2004WO2004058730A2 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
07/15/2004WO2004058729A1 New pyridazin-3(2h)-one derivatives
07/15/2004WO2004058727A1 Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
07/15/2004WO2004058722A1 Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
07/15/2004WO2004058721A2 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity
07/15/2004WO2004058718A1 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as caspase inhibitors
07/15/2004WO2004058714A1 Compounds useful as pesticides
07/15/2004WO2004058713A1 Differential tumor cytotoxocity compounds and compositions
07/15/2004WO2004058710A1 Novel benzamide derivatives and process for production thereof
07/15/2004WO2004058709A1 Ccr8 inhibitors
07/15/2004WO2004058705A2 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor
07/15/2004WO2004058704A2 Quinazolinones as potassium channel modulators
07/15/2004WO2004058702A2 4-[(4-(carboxyethyl) piperidinyl) methyl] pyrrolidines as modulators of chemokine receptor activity
07/15/2004WO2004058700A2 Mitotic kinesin inhibitors
07/15/2004WO2004058686A1 Hydroxypropyl amides for the treatment of alzheimer’s disease
07/15/2004WO2004058302A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia
07/15/2004WO2004058270A1 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases
07/15/2004WO2004058249A1 1,5-diaryl-pyrrole-3-carboxamide derivatives and their use as cannabinoid receptor modulators
07/15/2004WO2004058176A2 Acyclic pyrazole compounds
07/15/2004WO2004058144A2 Antibacterial agents
07/15/2004WO2004057960A2 Compounds useful as pesticides
07/15/2004WO2004048345A3 2,5-diketopiperazines for the treatment of obesity
07/15/2004WO2004046129A3 Novel anthranilamide insecticides
07/15/2004WO2004045536A3 Method and compositions for temporarily incapaciting subjets
07/15/2004WO2004043366A3 Sulfonamides
07/15/2004WO2004041163A3 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
07/15/2004WO2004039780A8 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds
07/15/2004WO2004039318A3 Anti-infective biaryl compounds